Baseline measures of both BMI and fat mass index were lower among patients who died before follow-up compared to those followed-up and there were differences among the three groups in sex, education attainment, CD4 count, and TB treatment history at NUSTART enrolment (Table 1). The gene discussed is CD4; the disease is tuberculosis.